PolyPid (PYPD) announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. Story brings over 25 years of leadership experience in the MedTech industry.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PYPD:
- Roth Capital healthcare analyst holds an analyst/industry conference call
- PolyPid Gains FDA Support for D-PLEX100 NDA Submission
- PolyPid receives pre-NDA meeting minutes for D-Plex supporting NDA submission
- PolyPid Expands Share Offering to Strengthen Financial Position
- PolyPid price target lowered to $9 from $10 at Roth Capital